Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1351 - 1375 of 1455 in total
Sapitinib has been used in trials studying the treatment and basic science of Neoplasms, Breast Cancer, Breast Neoplasms, Metastatic Cancer, and Metastatic Breast Cancer, among others.
Investigational
Bizelesin has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Experimental
OPC-51803 is the first nonpeptide vasopressin (AVP) V(2)-receptor-selective agonist. It is a V(2)-selective agonist that produces a significant antidiuretic action after single and multiple oral dosing in AVP-deficient and normal AVP states. It is useful therapeutic drug in the treatment of hypothalamic diabetes insipidus, nocturnal enuresis, and some kinds of...
Investigational
Raclopride has been used in trials studying Parkinson Disease.
Investigational
Relenopride has been used in trials studying the treatment of Chronic Idiopathic Constipation.
Investigational
Ataciguat has been investigated for the basic science of Aortic Valve Stenosis.
Investigational
Experimental
SR-9009 is a REV-ERB agonist. SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the viability of normal cells or tissues .
Experimental
Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
Investigational
Acifluorfen is a protoporphyrinogen oxidase inhibitor.
Experimental
Displaying drugs 1351 - 1375 of 1455 in total